Shock-absorbing ‘goo’ discovered in bone
Latest research shows that the chemical citrate – a by-product of natural cell metabolism – is mixed with water to create a viscous fluid that is trapped between… read more.
Latest research shows that the chemical citrate – a by-product of natural cell metabolism – is mixed with water to create a viscous fluid that is trapped between… read more.
FDA Highlights by Bruce Sylvester – Bazedoxifene, approved in Europe to treat osteoporosis, appears to stop the growth of breast cancer cells, even in therapy-resistant tumors, researchers from… read more.
Most currently available osteoporosis drugs like denosumab are antiresorptive: they curb bone loss by blocking the action of cells that break down bone (osteoclasts) during the normal process… read more.
Patients with systemic vasculitis who require steroids for long periods or who have multiple relapses are likely to have extensive, irreversible organ damage.
Interventions to physicians and patients improve osteoporosis treatment at low cost. Reminding primary care doctors to test at-risk patients for osteoporosis can prevent fractures and reduce health care… read more.
While scientific evidence suggests that less is typically more when it comes to diagnosing and treating low-back pain in the US, the number of expensive imaging exams and… read more.
Laser-based measurements are proving to be a promising method for the assessment of osteoporosis. The team led by Professor Jussi Timonen has developed an ultrasound technique that… read more.
World Health Matters (Sweden) – by Gary Finnegan – Scientists in Sweden believe that have identified a set of genetic variations which cause osteoporosis.
The majority of patients with chronic obstructive pulmonary disease (COPD) referred for pulmonary rehabilitation have multiple extra-pulmonary comorbidities, according to a new study from the Netherlands.
In Europe, osteoporotic fractures account for more Disability Adjusted Life Years (DALYs) lost than common cancers with the exception of lung cancer.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.